Study to probe early-onset Alzheimer's
Posted on: Saturday, 29 November 2008, 11:41 CST
The adult children of people with the inherited form of Alzheimer's disease are being sought for a new study of the rare disorder.
Three hundred adults with a biological parent diagnosed with a known genetic mutation causing the early-onset form of Alzheimer's are being sought for a six-year, $16 million study being funded by the U.S. National Institute on Aging, HealthDay News reported Friday.
Just 5 percent of Alzheimer's patients have the inherited form of the disease, which can affect people as young as 30.
The so-called Dominantly Inherited Alzheimer's Disease Network study is aimed at identifying changes in the brain that occur before symptoms of the brain disease appear. Researchers also hope to better understand the more common, late-onset form of Alzheimer's disease.
This collaborative, international effort will link a network of research sites in the United States, England and Australia to family members of people with these rare forms of Alzheimer's,
NIA Director Richard Hodes said in a statement. By sharing data within the network, we hope to advance our knowledge of the brain mechanisms involved in Alzheimer's, eventually leading to targets for therapies that can delay or even prevent progress of the disease.
Source: United Press International
Related Articles
- Alzheimer's Disease Drug Treats Traumatic Brain Injury
- Elan and Transition Therapeutics Achieve Patient Enrollment Target in Phase 2 Clinical Study of ELND005 (AZD-103) in Alzheimer's Disease
- Banner Alzheimer's Institute and Sun Health Research Institute Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimer's Disease
- Elan and Transition Therapeutics Dose First Patient in Phase 2 Clinical Study of ELND005 (AZD-103) in Alzheimer's Disease
- TorreyPines Therapeutics Completes Second Phase I Study for NGX267, a Selective M1 Agonist for the Treatment of Alzheimer's Disease
- TorreyPines Therapeutics Initiates Second Phase I Study for NGX267, a Selective M1 Agonist for Treatment of Alzheimer's Disease
- Blood Test to Detect Alzheimer's a Step Closer; Second Study Confirms DiaGenic ASA's Breakthrough Test Method for Alzheimer's Disease
- Obesity Linked to Alzheimer's Disease Protein
- Increase in Specific, Abnormal Brain Protein May Predict Onset of Alzheimer's Disease, Study Shows
- Folate May Reduce Risk of Alzheimer's Disease, New Study Suggests
 |
 |
User Comments (0)
RSS Feeds